Terms: = Kidney tumors AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Treatment
3 results:
1. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
Roskoski R
Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
[TBL] [Abstract] [Full Text] [Related]
2. Is there a financial disincentive to perform partial nephrectomy?
Tanagho YS; Figenshau RS; Sandhu GS; Bhayani SB
J Urol; 2012 Jun; 187(6):1995-9. PubMed ID: 22498206
[TBL] [Abstract] [Full Text] [Related]
3. Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.
Schlesinger-Raab A; Treiber U; Zaak D; Hölzel D; Engel J
Eur J Cancer; 2008 Nov; 44(16):2485-95. PubMed ID: 18783939
[TBL] [Abstract] [Full Text] [Related]
